Navigation Links
Photo: Introduction of the Amigo Insulin Pump Offers a Lifestyle Where 'Life Has No Limits'
Date:5/1/2008

MIRAMAR, Fla., May 1 /PRNewswire/ -- Nipro Diabetes Systems introduces the Amigo(R) Insulin Pump available for the first time to the market. The pump helps control blood glucose for children and adults with types 1 and 2 diabetes. Built for safety, reliability, accuracy and durability, the Amigo is user friendly with computer-like help screens for easy programming. Developed and manufactured in the United States by people with diabetes and healthcare professionals who specialize in the disease, the Amigo has been designed around the patient and in response to the ever changing treatment of diabetes.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/niprodiabetes/31430/

The Amigo Insulin Pump mimics the pancreas by consistently delivering basal insulin throughout the day and night and allowing the wearer to program bolus insulin whenever needed. It utilizes rapid-acting insulin that is very similar to the insulin produced by the human pancreas. The Amigo is also a smart pump because it is capable of calculating bolus insulin for food and high blood glucose readings through parameters prescribed by the physician and stored in the pump.

The Amigo's 'Life Has No Limits' campaign emphasizes the freedom for people with diabetes to take control of their lives instead of letting the disease control them. No matter what you eat, where you go, or what you do, the Amigo empowers you to participate in a wide variety of activities.

Nipro Diabetes Systems differentiates the Amigo Insulin Pump from other pumps in the market through its dedication to high quality customer service. Diabetes Educators are available 24 hours a day, 7 days a week to answer any questions. From education in carbohydrate counting to technical aspects of the Amigo Insulin pump, there is always a 'friend' a phone call way.

Charitable work is also part of Nipro's mission, with a portion of every Amigo sale going to the Kids on the GO Foundation. The charity was created to bring lower income children and their families together with kid-focused diabetes events. The funds will be utilized to help families cover the cost to attend diabetes conferences and camps.

Nipro Diabetes Systems is located in Miramar, Florida where the Amigo insulin Pump is manufactured and distributed along with diabetes supply products through our online store. The parent company, Nipro Corporation, is a multi-billion dollar company headquartered in Osaka, Japan that has been a leader in the healthcare field since 1954. For additional information on the Amigo Insulin Pump, call toll free 1-888-651-PUMP(7867) or log onto http://www.niprodiabetes.com.


'/>"/>
SOURCE Nipro Diabetes Systems
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Photo: Meet the F.A.T. Balance Characters!
2. Photo: Sweet Dreams From Turkey
3. Photo: Beverly Hills Liposculpture Specializes in Scarless Breast Reduction Dr. Alan Bittner Reduces Female Breasts by up to 50%
4. Photo: Animal Rescue League of Boston Receives $3 Million Grant to Establish a Center for Shelter Dogs
5. Photo: MultiVu Promotes George DeTorres to Divisional Vice President for the MultiVu Healthcare Team
6. Photo: KFC Colonel Original and Look-a-Like Share Eye Treatment Success Story
7. Photo: Two Men Raising Awareness of HIV/AIDS by Running Minimum of a Marathon a Day from San Francisco to Los Angeles
8. Photo: New Data Show Gleevec(R) Halts Progression to Advanced Stages of Life-Threatening Form of Leukemia in Sixth Year of Treatment
9. Photo: Scientists Complete Genome Sequence of Fungus Responsible for Dandruff, Skin Disorders
10. Photo: New York Goes Orange for Pumpkin Festival and Lupus Awareness Month
11. Video and Photo: Tasigna(R) Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Existing Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... , ... Only two months after the official release of The Private Collection ... XO Private has initiated a second print-run of its lavish luxury travel coffee table ... when open, weighs in at more than six kilos, retails at EUR 1,000 per ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... In the ... to be a top priority because it’s not if you will be attacked, but ... especially when it comes to digital health care. , Improvements in auditing and monitoring ...
(Date:2/24/2017)... ... ... The California State University Institute for Palliative Care is pleased ... palliative care education and research. The Symposium, “Innovate. Investigate. Educate: Advancing Academic Palliative ... Sept. 28 and 29, 2017, on the campus of California State University San Marcos. ...
(Date:2/24/2017)... ... February 24, 2017 , ... Rosica Communications, a national ... , media relations, social media, content marketing and SEO, is now offering direct, ... an intuitive marketing automation platform. , Rosica will now offer the platform to ...
(Date:2/23/2017)... , ... February 23, 2017 , ... The 89th Academy ... winner of the 2016 National Education Policy Center Bunkum Award. We invite you to ... 2016. , This year’s Bunkum winner is the Center for American Progress (CAP), for ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Feb. 24, 2017 Juan ... & Associates PC , a boutique securities firm headquartered ... York City , announces that a class action ... Massachusetts  against Inotek Pharmaceuticals Corporation (NASDAQ: ... the Company,s securities between July 23, 2015 and December 30, ...
(Date:2/24/2017)... , Feb. 23, 2017  Directors from Pharma To Market Pty ... have joined forces, resulting in the founding of Pharma To Market ... Pharma To Market are pleased to announce their expansion into ... Singapore . The company are delighted to appoint ... of the Singapore based entity. Joelle brings ...
(Date:2/24/2017)... , Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., ... announced that it has acquired exclusive worldwide rights ... best-in-class innovative HDAC inhibitor targeting hematological and solid ... 14 Phase 1 and 2 clinical trials of ... have already been completed, demonstrating that ...
Breaking Medicine Technology: